Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference
November 23 2016 - 8:00AM
Innocoll Holdings plc (Nasdaq:INNL), a global, specialty
pharmaceutical and medical device company with late stage
development programs targeting areas of significant unmet medical
need, today announced that Anthony Zook, Chief Executive Officer of
Innocoll Holdings plc, will participate in a fireside chat at the
Piper Jaffray Annual Healthcare Conference on Wednesday, November
30, 2016, at 1:30 p.m. ET at the Lotte New York Palace Hotel in New
York, NY.
About Innocoll Holdings plc
Innocoll is a global, specialty pharmaceutical company with late
stage development programs that is dedicated to engineering better
medicines to help patients get better. Our proprietary,
biocompatible, and biodegradable collagen products are
precision-engineered for targeted use. Applied locally to surgery
sites, they are designed to provide a range of benefits. The
company's late stage product pipeline is focused on addressing a
number of large unmet medical needs, including: XARACOLL for the
treatment of postoperative pain and COLLAGUARD (INL-003), a barrier
for the prevention of post-surgical adhesions.
Our currently approved products include: COLLAGUARD® (ex-US),
COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and
ZORPREVA®.
Corporate:
Pepe Carmona
Chief Financial Officer
(215) 983-3362
pcarmona@innocoll.com
Jeannie Sorenson, M.D.
Vice President, Investor Relations
(314) 458-7355
jsorenson@innocoll.com
Innocoll AG (NASDAQ:INNL)
Historical Stock Chart
From Apr 2024 to May 2024
Innocoll AG (NASDAQ:INNL)
Historical Stock Chart
From May 2023 to May 2024